chr12-56744111-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000946.3(PRIM1):c.592G>A(p.Val198Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000332 in 1,563,918 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000946.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRIM1 | NM_000946.3 | c.592G>A | p.Val198Ile | missense_variant | 6/13 | ENST00000338193.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRIM1 | ENST00000338193.11 | c.592G>A | p.Val198Ile | missense_variant | 6/13 | 1 | NM_000946.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152152Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000106 AC: 19AN: 178806Hom.: 0 AF XY: 0.0000735 AC XY: 7AN XY: 95286
GnomAD4 exome AF: 0.0000305 AC: 43AN: 1411648Hom.: 0 Cov.: 30 AF XY: 0.0000286 AC XY: 20AN XY: 698136
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152270Hom.: 0 Cov.: 31 AF XY: 0.0000537 AC XY: 4AN XY: 74456
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 24, 2023 | The c.592G>A (p.V198I) alteration is located in exon 6 (coding exon 6) of the PRIM1 gene. This alteration results from a G to A substitution at nucleotide position 592, causing the valine (V) at amino acid position 198 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at